Clinical Trials Directory

Trials / Completed

CompletedNCT03401177

Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs

The Effect of NSAIDs in the Early Phase of Achilles Tendinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

this study evaluates the addition of initial short term NSAID treatment to physiotherapy prescribed exercise treatment in patient with early phase tendinopathy. Half of the participants will initially receive NSAID (naproxen) for 7 days, while the other half will receive a placebo, where after both groups will be subjected to 3 months heavy slow resistance training.

Detailed description

NSAID is effective in short term pain relief in musculoskeletal disorders, but little is known about the long-term effect in early phase tendinopathy, when used as a supplement to treatment as usual, namely heavy slow resistance training and training load reduction. In this study, NSAIDs will be used, which works through COX inhibition, which again inhibits Prostaglandins, in this way investigators attempt to dampen the initial inflammation and pronounced cell activity that is thought to be present in early phase tendinopathy. With this project, it will be attempted to investigate whether initial dampening adds to the effect achieved through heavy load resistance training, which is thought to stimulate structural repair and regeneration in the tendon, by applying appropriate load to the tendon tissue, thereby stimulating the tendon cells to repair and regeneration.

Conditions

Interventions

TypeNameDescription
DRUGNaproxen 500 MgNaproxen is used as a tool to dampen the inflammation thought to be present in early phase Tendinopathy
DRUGPlacebo Oral TabletPlacebo is used, to provide a control to the active group.
OTHERHeavy resistance trainingHeavy slow resistance training - used in both groups subsequent to the initial week of NSAID or placebo treatment.

Timeline

Start date
2018-01-15
Primary completion
2019-07-31
Completion
2020-04-27
First posted
2018-01-17
Last updated
2020-07-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03401177. Inclusion in this directory is not an endorsement.